Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Exelon Corporation (NYSE:EXC)?

Is Exelon Corporation (NYSE:EXC) ready to raly soon? Hedge funds are turning bullish. The number of bullish hedge fund positions improved by 2 recently.

In the eyes of most stock holders, hedge funds are viewed as worthless, old financial tools of years past. While there are more than 8000 funds trading at present, we at Insider Monkey hone in on the moguls of this club, close to 450 funds. It is widely believed that this group controls the majority of the hedge fund industry’s total capital, and by tracking their best picks, we have unsheathed a number of investment strategies that have historically beaten the S&P 500 index. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 25 percentage points in 6.5 month (see the details here).

Exelon Corporation (NYSE:EXC)Just as important, positive insider trading sentiment is another way to break down the investments you’re interested in. As the old adage goes: there are plenty of motivations for an upper level exec to get rid of shares of his or her company, but just one, very clear reason why they would behave bullishly. Plenty of empirical studies have demonstrated the valuable potential of this method if investors know what to do (learn more here).

Keeping this in mind, it’s important to take a gander at the latest action surrounding Exelon Corporation (NYSE:EXC).

Hedge fund activity in Exelon Corporation (NYSE:EXC)

In preparation for this year, a total of 25 of the hedge funds we track were long in this stock, a change of 9% from the third quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were upping their stakes meaningfully.

Of the funds we track, Ken Griffin’s Citadel Investment Group had the most valuable position in Exelon Corporation (NYSE:EXC), worth close to $63 million billion, accounting for 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Carlson Capital, managed by Clint Carlson, which held a $37 million position; the fund has 0.6% of its 13F portfolio invested in the stock. Remaining peers that are bullish include John A. Levin’s Levin Capital Strategies, Sean Cullinan’s Point State Capital and Jonathan Kolatch’s Redwood Capital Management.

Consequently, key money managers have been driving this bullishness. Carlson Capital, managed by Clint Carlson, initiated the largest position in Exelon Corporation (NYSE:EXC). Carlson Capital had 37 million invested in the company at the end of the quarter. Sean Cullinan’s Point State Capital also made a $26 million investment in the stock during the quarter. The other funds with new positions in the stock are Jonathan Kolatch’s Redwood Capital Management, Charles Clough’s Clough Capital Partners, and Glenn Russell Dubin’s Highbridge Capital Management.

How are insiders trading Exelon Corporation (NYSE:EXC)?

Insider buying is most useful when the company in focus has experienced transactions within the past 180 days. Over the last half-year time frame, Exelon Corporation (NYSE:EXC) has seen 1 unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

With the results exhibited by the aforementioned tactics, everyday investors should always watch hedge fund and insider trading sentiment, and Exelon Corporation (NYSE:EXC) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!